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The polycyclic musks 6-acetyl-1,1,2,4,4,7-hexamethyltetraline
(AHTN) and 1,2,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcy-
clopenta-ç-2-benzopyran (HHCB) are used as fragrance
ingredients in perfumes, soaps, and household cleaning
products. They are known to be ubiquitously present in the
aquatic environment, and because of their lipophilic
nature, they tend to bioaccumulate in aquatic biota. In
surface waters, concentrations between 1 ng/L and 5 íg/L
have been found, depending mainly on the proportion of
sewage effluents in the water. In fish, under normal
environmental conditions, concentrations in the microgram
per kilogram fresh weight (fw) range are found. In a
previous study we showed that AHTN and HHCB exert
mainly antiestrogenic effects on the human estrogen receptor
R (ERR) and ERâ in an in vitro reporter gene assay. In
the current study, we assessed the in vitro antiestrogenic
effects of both musks on zebrafish ERs. Antagonism
was observed on zfERâ, and more pronounced on the
newly cloned zfERç. Using a transgenic zebrafish assay,
we studied antiestrogenicity of the musks in vivo. Dose-
dependent antagonistic effects were observed at
concentrations of 0.1 and 1 íM AHTN and HHCB. GC-
MS analysis showed that the musks bioaccumulated in the
fish, with internal concentrations (15-150 mg/kg fw)
which were roughly 600 times higher than the nominal
test doses. To our knowledge, this is the first time that
environmental contaminants are shown to be antiestrogenic
in an in vivo fish assay that focuses solely on ER-
mediated effects. This makes the transgenic zebrafish
assay a promising tool for the rapid detection of both
estrogenic and antiestrogenic effects of chemicals in fish.
Introduction
Two chemicals that are ubiquitously present in the aquatic
environment are the polycyclic musks 6-acetyl-1,1,2,4,4,7-
hexamethyltetraline (AHTN) and 1,2,4,6,7,8-hexahydro-
4,6,6,7,8,8-hexamethylcyclopenta-ç-2-benzopyran (HHCB).
Polycyclic musks are used as fragrance compounds in laundry
detergents, soaps, and cosmetics, with a worldwide produc-
tion volume of about 6000 tons per year (1). They may reach
the aquatic environment via wastewater treatment plants,
and consequently, because of their lipophilic character, they
tend to bioaccumulate in fish and other aquatic organisms.
Log Ko/w values of 5.7 and 5.9 have been found for AHTN and
HHCB, respectively (1). Concentrations of HHCB vary from
1 ng/L in clean surface waters up to 5 íg/L in surface water
with a high proportion of effluents of sewage treatment plants
(2, 3). In sewage water effluents concentrations of AHTN and
HHCB were found up to 4 and 13 íg/L, respectively (3).
Environmental concentrations of AHTN are usually lower,
reflecting its lower use volume (4). In eel (Anguilla anguilla)
samples from lakes with a high input of sewage water, AHTN
and HHCB concentrations were found up to 3 and 6.5 mg/kg
of lipid (0.7 and 1.5 mg/kg fresh weight (fw)), respectively,
with maximal concentrations which are 3 times higher (3).
In other fish species lower concentrations were found, due
to their lower fat content. Also in surface waters with a low
or moderate input of sewage water, lower concentrations in
the microgram per kilogram fw range were found.
Surprisingly, despite the fact that polycyclic musks are
ubiquitously present in the aquatic environment and tend
to bioaccumulate in aquatic biota, little is known of their
ability to disrupt endocrine systems, such as estrogen
homeostasis. Using cell lines stably transfected with an
estrogen-responsive reporter construct and the human
estrogen receptor R (ERR) or ERâ, we recently found that
both polycyclic musks show antiestrogenic and weak es-
trogenic effects, depending on the cell line and ER subtype
used (5). In the present study, we were interested to assess
the (anti)estrogenic effects of these compounds in fish.
Examples can be found of wild fish populations showing
disturbances of normal endocrine functions, and occurrences
of intersex and testis abnormalities (6-8). These effects have
been associated with the exposure to natural, synthetic, and
xenoestrogens in the aquatic habitats. Here, we assess the
(anti)estrogenic effects of AHTN and HHCB on the zebrafish
ERR, ERâ, and the recently cloned ERç (9), which is also
indicated as ERâ2 (10, 11). The experiments show no agonism
of the musks on all three receptors, but antagonism on zfERâ
and zfERç. Furthermore, we investigated the antiestrogenic
effects in vivo using a transgenic zebrafish assay (12), and we
correlated these effects to the measured internal dose. Both
AHTN and HHCB showed dose-dependent antagonistic
effects at test concentrations of 0.1 and 1 íM, and internal
doses which are roughly 600 times higher. As far as we know,
in vivo antiestrogenic effects of environmental contaminants
in fish have never been described before in the scientific
literature.
Materials and Methods
Chemicals and Reagents. 17â-Estradiol was purchased from
Sigma (St. Louis, MO). HHCB and AHTN were kind gifts from
International Flavours and Fragrances (IFF), Hilversum, The
Netherlands, and PFW-Aroma Chemicals, Barneveld, The
Netherlands, respectively. 4-Hydroxytamoxifen was a kind
gift from Dr. A. Wakeling (Zeneca Pharmaceuticals, Maccles-
field, U.K.).
Cell Culture. Human embryonal kidney 293 (HEK293)
cells were obtained from the American Type Culture Col-
lection (ATCC; Rockville, MD). Cells were maintained in a
1:1 mixture of Dulbecco's modified Eagle's medium (DMEM)
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and Ham's F12 medium (DF; Life Technologies Inc., Gaith-
ersburg, MD) supplemented with 7.5% fetal calf serum (FCS)
(Integro, Linz, Austria). The cell line was cultured at 37 °C
and 7.5% CO2.
Plasmids. The human ERR expression plasmid pSG5-
HEGO was kindly provided by Dr. P. Chambon (IGBMC,
Strasbourg, France). The human ERâ expression plasmid
pSG5-hERâ was kindly provided by Dr. J.-Å. Gustafsson
(Karolinska Institute, Huddinge, Sweden). The estrogen-
responsive reporter gene construct (3xERE-TATA-Luc), which
contains three copies of a consensus estrogen response
element (ERE) containing oligonucleotide and a TATA box
in front of the luciferase cDNA, is described in more detail
elsewhere (13). The cloning of the full-length zebrafish (zf)
ERR, zfERâ, and zfERç and the insertion into the EcoRI site
of the multiple cloning site of the pSG5 expression vector
(Stratagene) are described elsewhere (Zeinstra et al., manu-
script in preparation).
Transient Transfections. HEK293 cells were plated in 800
íL of phenol red-free DF medium containing 30 nM selenite,
10 íg/mL transferrin, and 0.2% BSA, supplemented with 5%
dextran charcoal stripped FCS, at 8  104 cells per well of a
24-well plate (Costar). Cells were transfected using the
calcium phosphate precipitation method (14) 30 h after
plating.
A total amount of 2.0 íg of DNA/well was transfected,
consisting of 0.6 íg of luciferase reporter plasmid, 0.6 íg of
PDM-LacZ internal control plasmid, 0.6 íg of pBluescript
SK-, and 0.2 íg of ER expression plasmid. After an overnight
incubation cells were given fresh media with or without test
compounds (dissolved in ethanol, maximum 0.1% solvent).
After 24 h, the cells were lysed in 200 íL of lysis solution
(1% Triton X-100, 25 mM glycylglycine, 15 mM MgSO4, 4 mM
EGTA, and 1 mM DTT). A 50 íL portion of cell lysate was
transferred to a black 96-well plate to which 50 íL of luciferine
substrate (LucLite reporter gene assay kit, Packard Instru-
ments, Meriden, CT) was added. Luciferase activity was
measured in a Topcount liquid scintillation counter (Packard
Instruments) for 0.1 min per well. To correct for variations
in transfection efficiencies, â-galactosidase activity was
measured (15).
Transgenic Zebrafish Assay. The development of the
transgenic zebrafish assay is described elsewhere (12).
Exposure studies were carried out with homozygous F4
juvenile fish of 4-5 weeks of age. Fish (n ) 5-6) were exposed
for 96 h in 200 mL of acclimated tap water (26-27 °C) in
beaker glasses. The compounds to be tested (dissolved in
DMSO) were added to the water in a 1:10000 dilution. Fish
were fed once daily with live brine shrimp (Artemia salinas).
Half of the test medium was renewed daily. At the end of the
exposure, fish were sacrified in ice-water, transferred to
Eppendorf vials, and immediately frozen at -80 °C. To assay
luciferase activity, Eppendorf vials containing whole fish were
transferred to ice, 500 íL of cold lysis solution (1% Triton
X-100, 25 mM glycylglycine, 15 mM MgSO4, 4 mM EGTA,
and 1 mM DTT, pH 7) was added, and the fish were
homogenized using a micropestle (Eppendorf). After cen-
trifugation at 12000 rpm for 15 min at 4 °C, duplicate samples
of 50 íL of supernatant were transferred to a black 96-well
plate (Packard) to which 50 íL of luciferine substrate (LucLite
reporter gene assay kit, Packard) was added. Luciferase
activity was measured in a scintillation counter (Packard
Topcount) for 0.1 min per well.
Internal Exposure. To assess the internal concentration
of both musks in the zebrafish, six animals were exposed to
0.1 or 1 íM (i.e., 25.8 or 258 íg/L) musk for 1, 2, 3, or 4 days.
Fish were exposed in 200 mL of acclimated tap water (26-27
°C) in beaker glasses. The compounds to be tested (dissolved
in DMSO) were added to the water in a 1:10000 dilution. Fish
were fed once daily with live brine shrimp (A. salinas). Each
day, before half of the test medium was refreshed, water
samples were taken. After exposure, fish were sacrificied,
and cleaned up for GC-MS analysis. The same exposure
experiment was done in the absence of zebrafish.
Extraction and Cleanup of Fish Samples and Water
Samples. Fish sacrificed on ice were spiked with 1 íg of AHTN
or HHCB as an internal standard, and ultrasonicated in a
mixture of 10 mL of water and 4 mL of cyclohexane. Then
4 g of dry NaCl was added, and after centrifuging, the upper
cyclohexane layer was transferred into a glass test tube. Again
4 mL of cyclohexane was added to the sample, and the
procedure was repeated. After concentration under nitrogen
to 1 mL, the organic layer was eluted on a silica column
using a 6 mL mixture of cyclohexane and ethyl acetate (98:2
v/v). The eluate was concentrated under nitrogen and
transferred into a vial for GC-MS analysis.
Water samples of 3 mL were extracted using 4 mL of
cyclohexane. The organic layer was spiked with either 1 íg
of AHTN or HHCB, concentrated under nitrogen, and
transferred into a vial for GC-MS analysis.
GC-MS Analysis. AHTN and HHCB concentrations in all
extracts were analyzed on a Carlo Erba 5300 GC (Milan, Italy)
equipped with a split/splitless injector, a 30 m  0.25 mm
(0.25 ím film thickness) fused silica DB-5MS column (J&W
Scientific, Folson, CA), and a QMD 1000 mass spectrometer
(Carlo Erba Instruments, Milan, Italy). Analyses were carried
out by splitless injection of 1 íL at 225 °C. The column
temperature was maintained at 90 °C for 1 min, and raised
by 30 °C/min to 150 °C followed by 4 °C/min to 210 °C. The
mass spectrometer was operated using selected ion moni-
toring (SIM), for m/z 243. Unknown concentrations were
quantified with the peak area ratio of the compound to be
quantified and the internal standard, using a standard curve.
The recovery of this method is 100%.
Data Analysis. Luciferase activity per well was measured
as light units. In the in vitro experiments, each concentration
was analyzed in triplicate. The luciferase activity per well
was divided by the concomitant â-galactosidase activity. In
the transgenic zebrafish assay five to six fish per concentration
were measured. From these values, the fold induction was
calculated by dividing the mean value in exposed and
nonexposed wells or fish. ERE-luc activity as a percentage of
estradiol induction is calculated by setting the fold induction
of estradiol at 100%. Data are mean values ( SEM from at
least three independent in vitro experiments or from 5-36
transgenic zebrafish. The EC50 values for the transient
transfections were calculated from sigmoidal dose-response
curves using the curve-fitter of GraphPad Prism 3.0. The R
of the fit of the curves was >0.99. EC50 values were calculated
by determining the concentration at which 50% of the
maximal luciferase activity was reached. An unpaired Stu-
dent's t test was used to compare differences between mean
values of two different treatments. Data for dose-response
studies were analyzed for statistical significance by one-way
ANOVA and a least significant difference (LSD) test. Differ-
ences of P < 0.05 were accepted as statistically significant.
Results
Human and Zebrafish ER Transactivation by Estradiol in
a Transiently Transfected HEK293 Reporter Cell Line. To
compare the human and zebrafish ERs for E2-induced
transcriptional activation, we used the HEK293 cell line. This
cell line lacks significant endogenous levels of ER, can be
easily transfected, and has been shown to be highly responsive
to estrogens in transient transfections (16). Cells were
transiently transfected with one of the tested ER expression
plasmids and a reporter construct, consisting of three EREs
upstream from a TATA box in front of luciferase cDNA.
Dose-response curves of E2 are shown in Figure 1.
Transcriptional activity at hERR was about 1 order of
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magnitude higher than that of hERâ (Figure 1A), with EC50
values of 0.009 and 0.10 nM, respectively. When the zebrafish
ERs were compared, ERç was the most responsive to E2,
suggesting an important role in estrogen regulation (Figure
1B). Zebrafish ERR and ERâ were about equally sensitive,
but less sensitive than zfERç. We found EC50 values of 0.38,
0.73, and 0.09 nM for zfERR, zfERâ, and zfERç, respectively.
Comparison of human and zebrafish ERs revealed that E2-
induced transcriptional activity of the human ERR was about
40 times higher than its zebrafish counterpart, while human
ERâ was only about 7 times more responsive than zfERâ.
Together with the small difference in sensitivity between
zfERR and zfERâ, in contrast to the human ERs, these findings
may suggest that zfERâ, compared to its ERR counterpart,
is relatively more sensitive to estrogens than hERâ. These
findings are consistent with another study (9). In addition,
we used the dose-response curves to determine the sub-
maximal E2 dose for each receptor subtype. At this con-
centration the response can be influenced most sensitively
and can therefore be used in competition experiments, to
assess antiestrogenicity.
Inhibition of E2-Induced Transactivation of Human and
Zebrafish ER by AHTN and HHCB. To assess the anti-
estrogenic effects of AHTN and HHCB, we dosed the
transiently transfected HEK293 cells with different concen-
trations of musk, and a submaximal concentration of
estradiol. A submaximal dose of 0.01 nM E2 was used for
hERR-mediated experiments, a dose of 0.1 nM was used for
hERâ and zfERç, and 1 nM E2 was used for zfERR and zfERâ.
AHTN and HHCB alone showed a marginal transcriptional
activation of the human ERR, at the highest test concentration
of 10 íM. This was also previously shown in stably transfected
HEK293 cells (5). Neither of the musks could stimulate
transcriptional activity of the zebrafish ERs and the human
ERâ (data not shown). As a positive control for antiestro-
genicity in this experiment, the well-known antiestrogen
4-hydroxytamoxifen (OHT) was used at a concentration of
0.01 íM. OHT strongly inhibited the E2-stimulated tran-
scriptional activation of all tested estrogen receptors (Figure
2). A clear dose-dependent and significant suppression of E2
FIGURE 2. Repression of transcription of hERr (A), hERâ (B), zfERr
(C), zfERâ (D), or zfERç (E) by OH-tamoxifen (black bar; 0.01 íM),
AHTN (white bars; 0.1-10 íM), and HHCB (gray bars; 0.1-10 íM)
in transiently transfected HEK293 cells. Results are expressed as
a percentage of submaximal E2 induction of each receptor subtype
(hERr, 0.01 nM; hERâ, 0.1 nM; zfERr, 1 nM; zfERâ, 1 nM; zfERç, 0.1
nM). Values represent means ( SEM from three independent
experiments with each concentration measured in triplicate. Key:
*, P < 0.05; **, P < 0.01; ***, P < 0.001 (by one-way ANOVA and
LSD for differences between E2 treatment alone and E2 + compound).
FIGURE 1. Activation of transcription of hERr and hERâ (A) and
zfERr, zfERâ, and zfERç (B) by 17â-estradiol in transiently transfected
HEK293 cells. Results are expressed as a percentage of maximal
E2 induction of each receptor subtype. Values represent means (
SEM from three independent experiments with each concentration
measured in triplicate.
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induction by AHTN and HHCB was shown toward human
ERâ and zebrafish ERç (Figure 2B,E). A weak antagonistic
effect could be observed on human ERR and zfERâ only at
the highest test concentration of 10 íM (Figure 2A,D), whereas
no effect was seen at zfERR (Figure 2C). Coadministration of
the musks with higher concentrations of E2 abolished the
antagonistic effects of the musks, which suggests a competi-
tive interaction at the level of the ER (data not shown).
Inhibition of E2-Induced Transactivation by AHTN and
HHCB in Transgenic Zebrafish. Since both musks antago-
nized E2-induced transcription on the zebrafish ERâ and
ERç in vitro, we wished to examine whether these anties-
trogenic effects could also be observed in vivo. Therefore,
we used a transgenic zebrafish assay, a rapid and specific in
vivo assay for the detection of (xeno)estrogens (12). In these
zebrafish, the same reporter gene construct was stably
introduced as the one that was used in the HEK293 transient
transfections. High responsiveness has been shown to natural
and synthetic (xeno)estrogens, such as estradiol, estrone,
DES, ethinyl estradiol, and DDT (12). The detection limit of
this assay is about 0.3 nM E2, and the EC50 is about 10 nM
E2 (9). When AHTN or HHCB was tested, concentrations of
10 íM were toxic to the fish. Both AHTN and HHCB did not
show any estrogenic effect in this in vivo assay (data not
shown).
We assessed for antiestrogenicity at the EC50 of the dose-
response curve of E2, namely, at 10 nM E2. At this
concentration, the positive control OHT showed a clear
inhibition of E2-stimulated transactivation (Figure 3). Both
HHCB and AHTN showed dose-dependent antagonistic
effects at concentrations of 100 and 1000 nM. The anties-
trogenic effects were still present at 100 nM E2, the maximum
of the dose-response curve, but less pronounced (data not
shown). Compared to OHT, the musks were about 2 orders
of magnitude less effective in reducing luciferase activity.
GC-MS Analysis of AHTN and HHCB during the Trans-
genic Zebrafish Assay. Fish were exposed to 0.1 or 1 íM (i.e.,
25.8 or 258 íg/L) musk for 1, 2, 3, or 4 days. Each day, before
half of the test medium was refreshed, water samples were
taken. Results are shown in Table 1. Both in the absence and
in the presence of zebrafish, immediately after dosing (t )
0), 10-35% of the musk has disappeared from the water,
either by absorption at the glass or by diffusion into the air.
At the end of the 96 h exposure without zebrafish, water
concentrations were 25-40% lower than the nominal con-
centration. In the presence of fish, concentrations in the
water at the end of the 96 h exposure were about 1.5 and 13
íg of AHTN/L and 2.9 and 15 íg of HHCB/L, for the low and
high doses, respectively. These concentrations were reached
within 24 h, and remained essentially unchanged thereafter.
We found that the internal concentration also stayed
roughly the same during the 4-day exposure (Figure 4). Only
AHTN at the highest test dose showed a significant increase
at day 3. In fish exposed to 0.1 íM AHTN, about 15.8 mg/kg
fw (i.e., 61 íM) was found, while fish exposed to 1 íM AHTN
contained about 143 mg/kg fw (i.e., 554 íM). Fish exposed
to 0.1 íM HHCB contained approximately 18.9 mg/kg fw
(i.e., 73 íM) and fish exposed to 1 íM HHCB about 135
mg/kg fw (i.e., 523 íM). This means that the internal
concentration is about a factor 600 higher than the nominal
test dose.
Discussion
In this study we were mainly interested in the in vitro and
in vivo antiestrogenic effects of two polycyclic musks (AHTN
and HHCB), which are ubiquitously present in the aquatic
environment. For the in vitro experiments, we used the ERR
and ERâ subtypes cloned from human and zebrafish, and
also the novel zebrafish ERç (9). Next to ERR and ERâ, fish
have a third ER subtype (ERâ2 or ERç), which has been
recently discovered in the Atlantic croaker (17), goldfish (18),
and the zebrafish (10, 11, 19; see also Callard et al.,
unpublished results; GenBank Nos. AAK16740, AAK16741,
and AAK16742). Comparison of the overall amino acid
sequences of the three receptors indicates that each zfER
protein was generated by a distinct gene (11). Alignment of
FIGURE 3. Luciferase activity in juvenile transgenic zebrafish
exposed for 96 h to 10 nM estradiol together with OHT (black bars;
1-100 nM), AHTN (white bars; 0.01-1 íM), or HHCB (gray bars;
0.01-1 íM). Results are expressed as a percentage of E2 induction.
Values represent means ( SEM from 5-36 fish. The number in the
bar represents the number of fish tested. Key: *, P < 0.05; **, P <
0.01; ***, P < 0.001 (by one-way ANOVA and LSD for differences
between E2 treatment alone and E2 + compound).
TABLE 1. Concentrations of AHTN and HHCB Determined in
Test Water during the Internal Exposure Experimenta
water concn (íg/L)
absence of fish presence of fish
compd
nominal
concn t ) 0 h t ) 24 h t ) 96 h t ) 0 h t ) 24 h t ) 96 h
AHTN 25.8 18 17 15 18 1.3 1.5
258 229 232 196 227 14 13
HHCB 25.8 22 18 16 20 2.7 2.9
258 176 173 158 169 17 15
a See Materials and Methods for details. Concentrations are ex-
pressed as micrograms per liter.
FIGURE 4. Internal concentrations of AHTN and HHCB at nominal
test concentrations of 0.1 (bottom part of graph) and 1 íM (top part
of graph) during the 4-day internal exposure experiment. Results
are expressed as milligrams of musk per kilogram fresh weight.
Values represent means ( SEM from 5-6 fish. Key: *, P < 0.05;
**, P < 0.01 (by Student's t test for differences between day 1 and
the following days).
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the ligand binding domains of the human and the zebrafish
ERR reveals a homology of 55%. The percentage of identical
amino acid residues of the human and the zebrafish ERâ is
57%, and that of hERâ and zfERç is 61% (11). These alignment
results taken together with phylogenetic analysis clearly
indicated that zfERR belongs to the ERR subgroup and that
both zfERâ and zfERç belong to the ERâ subgroup (11).
The zebrafish ER subtypes, which have been cloned in
our laboratory, have been shown to bind estradiol in a
receptor-binding assay (Zeinstra et al., manuscript in prepa-
ration). This was partly to be expected, since all three zebrafish
ERs contain the same specific amino acids for estradiol
binding as are found in the human ERR, i.e., Glu353, Arg394,
and His524 in hERR (20). In the present results we show that
zebrafish ERç is the most sensitive to estradiol, which was
also shown in other studies (9, 11). Furthermore, the
difference between E2-stimulated transactivation of human
ERR and ERâ was not shown in the zebrafish situation, where
ERR and ERâ are about equally potent and ERç is the most
responsive transactivator. Overall, zebrafish ERR and ERâ
are less sensitive to E2 than their human counterparts, which
also has been shown for rainbow trout ERs (21). This may
explain the fact that both musk compounds do not show any
agonistic effect on the three zebrafish ERs. On the human
ERR, the transactivation potential of which is minimally a
factor of 10 higher than those of the zebrafish ERs, a marginal
agonism has been shown in stably transfected HEK293 cells
(5). On the other hand, antiestrogenic effects of AHTN and
HHCB on the human ERs have been recently shown (5). In
the present study we also showed a dose-dependent an-
tagonism on zfERç, already starting at 100 nM and which is
almost as strong as that on hERâ. Of the three zebrafish ERs,
zfERç showed the highest susceptibility for suppression of
E2 induction by OHT and both musks.
In our in vivo transgenic zebrafish study, at test concen-
trations of 0.1 and 1 íM AHTN or HHCB, a significant
repression of E2-induced transactivation was observed,
especially at the EC50 E2 concentration. This repression is
quite strong, namely, down to 20% of the E2 induction for
both compounds at the highest test dose.
The nominal water concentrations used in this in vivo
study (0.01, 0.1, and 1 íM musk, i.e., 2.58, 25.8, or 258 íg/L
musk) were comparable to the nominal concentrations used
in standard fish toxicity studies. In a 36-day early-life-stage
test (OECD 210) with fathead minnow (Pimephales promelas)
no observed effect concentrations (NOECs) were found of
35 íg of AHTN/L and 68 íg of HHCB/L. In a 21-day growth
test (OECD 204) with bluegill sunfish (Lepomis macrochirus)
NOECs were found of 89 íg of AHTN/L and 93 íg of HHCB/L
(22). The actual concentrations at which we observe anti-
estrogenic effects are around or below the no-observed-effect
levels from these studies. That is, no developmental disorders
were or will be observed at the concentrations used in our
transgenic zebrafish assay.
Furthermore, the nominal concentrations at which an
antiestrogenic effect is observed are roughly 25 to more than
1000 times higher than the concentrations found in the
environment. Under normal environmental conditions, in
river and seawater, levels of musk in the nanogram per liter
range are found (reviewed in refs 23 and 24). The higher the
input of sewage water, the higher the concentration of musk
that is found (3). Maximum levels in the low microgram per
liter range have been found in water samples from lakes with
a high input of sewage water. Higher concentrations have
been found in sewage water effluents and sewage settlement
ponds, with maximal levels in eel of 19.2 mg/kg fw (cited in
ref 25). In eel under natural conditions mean levels of 43
íg/kg fw were found (cited in ref 3). In other fish species
under natural conditions, comparable or lower concentra-
tions are found, depending largely on the lipid content
(reviewed in refs 23 and 24). The internal concentration that
we have found at the lowest observed effect concentration
for antiestrogenicity in vivo (i.e., 0.1 íM) is about 15.8 mg of
AHTN/kg fw and 18.9 mg of HHCB/kg fw. These concentra-
tions can be reached in fish from ponds of sewage treatment
plants (24, 25) and might induce antiestrogenic effects in
this particular situation. Under normal environmental con-
ditions, the concentrations of the musks in receiving waters
are too low to cause antiestrogenic effects.
Concentrations in the fish depend on the toxicokinetics
and the biotransformation of the compound in the fish. The
high antagonistic potency in vivo may be due to its high
lipophilicity and thus to its strong bioaccumulation. From
our GC-MS results it is clear that both musks are indeed
bioaccumulating. In the zebrafish, concentrations have been
found which are roughly a factor 600 higher than the nominal
test dose. Internal concentrations stay roughly the same
during the 96 h in vivo experiment, which means that the
equilibrium has been reached within 1 day. Butte et al. (26)
showed that for both polycyclic musks the steady state for
uptake in zebrafish was reached in about 10 h. Concentrations
in the fish also depend on the fate of the compound in the
aquarium. When AHTN or HHCB is added to beaker glasses
without fish, immediately after the first dosing, 15-30% has
disappeared, and at the end of the 96 h experiment, 25-40%
has disappeared. Compounds may sorb to the glass wall and
detritus, or degradation of the compounds may take place.
HHCB can be transformed into HHCB lactone by autoxi-
dation, which can also occur as a biotransformation reaction
(27). Nevertheless, a significant amount of musk has been
accumulated in the fish, resulting in low actual water
concentrations at the end of the exposure experiment, and
also in the observed antiestrogenic effects.
The antiestrogenic effects seen in the in vivo transgenic
zebrafish assay are probably for the greater part mediated
by the zfERç, which is the most responsive to estradiol in our
in vitro assays. Also, the strongest antagonism by the musks
was seen at this receptor subtype. However, it cannot be
ruled out that the other two ER subtypes also play a role in
the netto effect. Comparison between the in vitro system
and the in vivo test system is possible because the measured
end point (luciferase protein) is induced according to the
same principle. In both assays the compound binds to the
endogenous ER and activates it. Then the ER-ligand complex
binds to EREs present on the luciferase target gene, which
is introduced in the genome of both the cells and the fish.
Finally the luciferase protein is induced. To our knowledge,
this is the first time that environmental contaminants are
shown to be antiestrogenic in an in vivo fish assay. In scientific
literature, antiestrogenic effects have been observed in
cultured fish hepatocytes by measuring the concentration
or expression of the estrogen-regulated yolk protein vitel-
logenin (Vtg) (28, 29). Letcher et al. (29) showed the
antiestrogenic effects of PCB metabolites in an in vitro carp
hepatocyte assay by measuring Vtg, and made clear that these
effects were ER-mediated, rather than aryl hydrocarbon
receptor (AhR)-mediated. Monteverdi and Di Giulio (30) and
Latonnelle et al. (28) observed antiestrogenic effects of
tamoxifen in, respectively, channel cat fish and Siberian
sturgeon hepatocyte cultures, by showing repressed Vtg
synthesis. These effects were also postulated to be ER-
regulated. However, these studies are in vitro studies, lacking
important aspects of in vivo functioning, such as kinetics
and biotransformation.
Several in vivo studies looked at the downregulation of
Vtg synthesis by antiestrogenic AhR agonists. AhR agonism
is assessed by measuring CYP1A induction. TCDD and
nonortho PCBs function via an AhR-mediated mechanism
of action, involving cross-talk between the ER and the AhR
(31). In an in vivo study by Arukwe and collegueas (32), the
VOL. 38, NO. 4, 2004 / ENVIRONMENTAL SCIENCE & TECHNOLOGY 9 1001
antiestrogenic CYP1A inducer 3,3′,4,4′-tetrachlorobiphenyl
(TCB) shows both potentiation and reduction of nonylphenol-
induced Vtg synthesis, depending on doses and temporal
exposure sequence. Another in vivo study shows both
potentation and repression of E2-induced Vtg synthesis by
the CYP1A inducer â-naphthoflavone, which has been shown
to be antiestrogenic in vitro (33). These studies assessed
antiestrogenicity which is both ER- and AhR-mediated. Only
a few in vivo fish studies showed antagonism that was
postulated to be solely ER-dependent. Tilapia showed
decreased E2-induced Vtg levels after tamoxifen exposure
for 12 days (34). Similar results were found in exposed female
Tilapia by Lazier et al. (35). Recently, Panter et al. (36) exposed
fathead minnows via the water. However, no dose-dependent
antagonism was found when fish were exposed to ethi-
nylestradiol and the antiestrogen ZM189,154. Using an AhR-
specific CALUX assay, we showed no in vitro (ant)agonistic
effects of the musks on the human AhR (unpublished data).
Furthermore, AHTN is not a CYP1A inducer (37). We conclude
that, in our in vivo assay, the observed antiestrogenic effects
are not AhR-mediated, but solely ER-mediated. This makes
the transgenic zebrafish assay a suitable tool for the rapid
detection of both estrogenic and antiestrogenic effects of
chemicals in an in vivo fish model.
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